Company Filing History:
2 out of 70 
1 out of 9 Years Active: 2016-2020
Title: **Chengyong Shen: Innovating in Neurotransmission Disorder Treatments**
Introduction
Chengyong Shen, an accomplished inventor based in Augusta, GA, is recognized for his contributions to the field of neurobiology. With a total of three patents to his name, Shen has made significant strides in the detection and treatment of neurotransmission disorders, improving the lives of patients affected by such conditions.
Latest Patents
Shen's most recent patent focuses on the detection and treatment of LRP4-associated neurotransmission disorders. This invention presents methods for identifying neurotransmission or developmental disorders, including myasthenia gravis that is seronegative for autoantibodies to the acetylcholine receptor (AChR) and muscle-specific tyrosine kinase (MuSK). The method involves detecting autoantibodies that bind to LRP4 or an epitope thereof. Furthermore, it outlines therapeutic approaches for individuals suffering from these disorders, emphasizing the administration of immunosuppressants or other appropriate treatment modalities. This patent also includes the development of antibodies targeting autoantibodies to LRP4 and kits designed for the detection of neurotransmission or developmental disorders.
Career Highlights
Chengyong Shen has made impactful contributions through his work at prominent research institutions, including Augusta University Research Institute, Inc. and Georgia Regents Research Institute, Inc. His innovative endeavors have positioned him at the forefront of neuroscience research, particularly in the realm of developing diagnostic and therapeutic solutions for complex neurotransmission disorders.
Collaborations
Shen has collaborated with notable colleagues such as Lin Mei and Wen-Cheng Xiong, enriching his research with diverse perspectives and expertise. These collaborations have played a crucial role in advancing the understanding and treatment of neurotransmission-related conditions.
Conclusion
Through his innovative patents and collaborative efforts, Chengyong Shen continues to push the boundaries of neurobiology, contributing significantly to the detection and treatment of neurotransmission disorders. His work not only exemplifies the spirit of innovation but also offers hope for many individuals affected by these challenging conditions.